Pathogenesis and Treatment of Alcoholic Liver Disease

Displaying 1 - 9 of 9CSV
Guzmán, D. S., Rentería, M. A., Avila, J. F., Turney, I. C., Johnson, A. S., Smith, A. C., Okafor, A., Houlihan, H. M., Heuer, L. B., Alshikho, M. J., Morales, C., Mazen, J., Gu, Y., Manly, J. J., Brickman, A. M., & Lao, P. J. (2024). Differential association of moderate alcohol use with neurodegeneration, cerebrovascular disease, and cognition by racial, ethnic and sex/gender groups in middle age. Alzheimer’s & Dementia, 20(S9). Portico. https://doi.org/10.1002/alz.093980
Publication Date
Guzmán, D. S., Rentería, M. A., Avila, J. F., Turney, I. C., Johnson, A. S., Smith, A. C., Okafor, A., Houlihan, H. M., Heuer, L. B., Alshikho, M. J., Morales, C., Mazen, J., Gu, Y., Manly, J. J., Brickman, A. M., & Lao, P. J. (2024). Differential association of moderate alcohol use with neurodegeneration, cerebrovascular disease, and cognition by racial, ethnic and sex/gender groups in middle age. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.091479
Publication Date
Al-Karaghouli, M., Ventura-Cots, M., Wong, Y. J., Genesca, J., Bosques, F., Brown, R. S., Mathurin, P., Louvet, A., Shawcross, D., Vargas, V., Verna, E. C., Schnabl, B., Caballeria, J., Shah, V. J., Kamath, P. S., Lucey, M. R., Garcia-Tsao, G., Bataller, R., & Abraldes, J. G. (2024). Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design. Hepatology Communications, 8(8). https://doi.org/10.1097/hc9.0000000000000495
Publication Date
Li, X., Bhattacharya, D., Yuan, Y., Wei, C., Zhong, F., Ding, F., D’Agati, V. D., Lee, K., Friedman, S. L., & He, J. C. (2024). Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH). Kidney International, 105(3), 540–561. https://doi.org/10.1016/j.kint.2023.12.009
Publication Date
Hagström, H., Thiele, M., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J., Sundström, J., & Ludvigsson, J. F. (2023). Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease. Clinical Gastroenterology and Hepatology, 21(7), 1841-1853.e12. https://doi.org/10.1016/j.cgh.2022.10.022
Publication Date
Prasad, M., Corban, M. T., Godo, S., Ben-Ami, J., Nardi, V., Toya, T., Gulati, R., Rihal, C. S., Lerman, L. O., & Lerman, A. (2023). SERUM URIC ACID, CORONARY PLAQUE CHARACTERISTICS, AND LONG-TERM MORTALITY AFTER PERCUTANEOUS CORONARY INTERVENTION. Journal of the American College of Cardiology, 81(8), 1279. https://doi.org/10.1016/s0735-1097(23)01723-0
Publication Date
Dienstag, A., Dienstag, P., Mohan, K., Mirza, O., Schubert, E., Ford, L., Edelman, M., Im, G., & Shenoy, A. (2022). An Assessment of the Psychosocial Evaluation for Early Liver Transplantation in Patients With Acute Alcoholic Hepatitis in the Context of Alcohol Use Disorder, a Case-Control Study. Substance Abuse: Research and Treatment, 16. https://doi.org/10.1177/11782218221115659
Publication Date
Jiménez, C., Ventura‐Cots, M., Sala, M., Calafat, M., Garcia‐Retortillo, M., Cirera, I., Cañete, N., Soriano, G., Poca, M., Simón‐Talero, M., Altamirano, J., Lucey, M., Garcia‐Tsao, G., Brown, R. S., Schwabe, R. F., Verna, E. C., Schnabl, B., Bosques‐Padilla, F., Mathurin, P., … Vargas, V. (2022). Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH). Liver International, 42(5), 1109–1120. Portico. https://doi.org/10.1111/liv.15207
Publication Date
Hagström, H., Thiele, M., Simon, T. G., Sharma, R., Röckert Tjernberg, A., Roelstraete, B., Söderling, J., & Ludvigsson, J. F. (2022). Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease. United European Gastroenterology Journal, 10(2), 198–211. Portico. https://doi.org/10.1002/ueg2.12200
Publication Date